Legionella Testing Market Report provides an Analysis on the Industry Trends in Each of the Sub-Segments from 2013 to 2025Legionella Testing Market Report provides an Analysis on the Industry Trends in Each of the Sub-Segments from 2013 to 2025

Global Legionella Testing Market is expected to reach USD 352.6 million by 2025, according to a new study by Grand View Research Inc. The increasing prevalence of Legionella-related disorders, along with requirements of rapid diagnostic procedures, is expected to drive the industry growth.

According to CDC, the number of people suffering from Legionnaires’ disease was 4,548 in 2013. The incidence of pneumonia and related disorders is constantly rising due the contaminated environment. The rising incidence of Legionellosis will drive the market growth in the coming years, especially in the industrial sector.

The conventional bacterial testing is least preferred nowadays, since it is labour intensive and time consuming. Against the difficulties faced due to the conventional microbial testing methods, rapid automated tests are gaining popularity in the industry.

Access for Full detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/legionella-testing-market

Further Key Findings from the Study Suggest:

• Water testing has been identified as the largest testing type segment in terms of revenue, due to increased water testing activities in various industries as a preventive measure to control infections
• Water testing has also been projected as fastest growing segment over the forecast period followed by IVD testing
• Among the types of water testing applications, microbial culture held the majority of market share in 2015 in terms revenue
• On the other hand, PCR is expected to be the fastest growing water testing type over the forecast period
• Urine antigen tests were identified as the largest IVD testing segment, while PCR is projected to be the fastest growing segment
• Key market players in Legionella testing market include Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Alere, Inc.; Roche Diagnostics; Thermo Fischer Scientific, Inc.; and Becton, Dickinson and Company (BD)

View Blog on Legionella Testing Market by Grand View Research: http://www.grandviewresearch.com/blog/legionella-testing-market-size-share 

Grand View Research has segmented the legionella testing market on the basis of application, type, and region:

Legionella Testing Application Outlook (Revenue, USD Million, 2013 - 2025)

• Water Testing
  • Microbial Culture
  • DFA Stain
  • PCR
  • Others
• IVD Testing
• Blood Culture
• Urine Antigen Test
• DFA Stain
• PCR
• Others

Legionella Testing Regional Outlook (Revenue, USD Million, 2013 - 2025)

• North America
  • U.S.
  • Canada
• Europe
• UK
• Germany
• Japan
• China
• India
• Brazil
• Mexico
• South Africa
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Carbide Tools Market to Gain from Enhanced Used In Machining Application 2025: Grand View Research, Inc.

Carbide Tools Market to Gain from Enhanced Used In Machining Application 2025: Grand View Research, Inc.: Carbide Tools, Carbide Tools Industry, Carbide Tools Market, Carbide Tools Market Trends, Carbide Tools Industry Trends, Carbide Tools Market Share, Carbide Tools Market Growth, Carbide Tools Market Size, Carbide Tools Manufacturer, Carbide Tools Market S

Bullet Proof Jacket Market to Witness Enhanced Usages for Armed Forces & Law Enforcement till 2025: Grand View Research, Inc.

Bullet Proof Jacket Market to Witness Enhanced Usages for Armed Forces & Law Enforcement till 2025: Grand View Research, Inc.: Bullet Proof Jacket, Bullet Proof Jacket Industry, Bullet Proof Jacket Market, Bullet Proof Jacket Market Trends, Bullet Proof Jacket Industry Trends, Bullet Proof Jacket Market Share, Bullet Proof Jacket Market Growth, Bullet Proof Jacket Market Size

Burner Management System (BMS) Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2025: Grand View Research, Inc.

Burner Management System (BMS) Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2025: Grand View Research, Inc.: Burner Management System, Burner Management System Industry, Burner Management System Market, Burner Management System Market Trends, BMS Industry Trends, Burner Management System Market Share, BMS Market, BMS Industry Outlook

Third Party Logistics (3PL) Market Analysis and Forecast Include Current Capacity and Expected Capacity Additions up to 2025

Global Third Party Logistics (3PL) Market is expected to reach USD 1.24 trillion by 2025, according to a new report by Grand View Research, Inc. The increasing outsourced-logistics functions availed by middle market companies to address their logistics challenges, are expected to positively impact the industry growth.

The domestic and global markets for outsourced-logistics services are continuously evolving toward advanced services and cloud-based technologies. The diligence related to logistics costs has led to an increased focus on the key concerns such as supply chain sustainability and security. Lowering of inventory costs is becoming a norm in the automotive and retail sectors, which is providing ample growth opportunities for 3PL providers.

Third party logistics providers are strengthening their relationships with freight providers to optimize their supply chain capabilities. They are also investing in contemporary IT solutions, commercial offerings, cloud-based solutions, and proprietary innovations to create a leading-edge approach. Though the economic conditions are varying across countries, significant improvements are visible in the key regions of Asia Pacific and North America.

3PL providers allow businesses to focus on their core activities such as R&D, manufacturing, and strategic planning, thereby relieving them from the daily burden of operational logistics issues. The key 3PL vendors use advanced applications and IT software, which enhance their distribution coverage and provide quality services to the customers. Omni channel distribution has gained momentum in the past few years, primarily due to the increased penetration of e-commerce.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/third-party-logistics-market

Further key findings from the report suggest:

• The value added logistics services segment is expected to be the fastest-growing segment, owing to the increasing need for inventory management and improved cycle times
• The retail sector is expected to grow at a CAGR of over 7.5%; this growth can be attributed to the evolution of Omni channel retailing and the need for data-driven analytics solution to manage fleet and warehousing
• Airways are expected to witness the fastest growth over the forecast period as consumers are willing to pay a premium price to receive products at the earliest
• The Middle East 3PL market is expected to reach a revenue share of over 8.5% by 2025, due to the increase in imports and exports and an upward trend in local manufacturing
• The key industry players include DHL, FedEx Corporation, C.H. Robinson Worldwide, UPS Supply Chain Solutions, and Kuehne + Nagel International AG
• Several organizations are transitioning toward 3PL vendors to deliver enhanced transportation management services for increased visibility and predictability

View Blog on Third Party Logistics (3PL) Market by Grand View Research: http://www.grandviewresearch.com/blog/third-party-logistics-3pl-market-size-share

Grand View Research has segmented the Third Party Logistics (3PL) market based on service, transport, end-use, and region:

3PL Service Outlook (Revenue, USD Billion, 2014 - 2025)

• Dedicated Contract Carriage (DCC)/Freight forwarding
• Domestic Transportation Management (DTM)
• International Transportation Management (ITM)
• Warehousing & distribution
• Value added logistics services

3PL Transport Outlook (Revenue, USD Billion, 2014 - 2025)

• Roadways
• Railways
• Waterways
• Airways

3PL End-Use Outlook (Revenue, USD Billion, 2014 - 2025)

• Manufacturing
• Retail
• Healthcare
• Automotive
• Others

3PL Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• Australia
• Latin America
• Brazil
• Mexico
• Middle East and Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Transfection Reagent and Equipment Market Forecasting Include Market usage and adoption trends

Global Transfection Reagent & Equipment Market is expected to reach USD 1,086.02 million by 2022, according to a new report by Grand View Research, Inc. This anticipated growth in demand can be attributed to growing need for protein production, biopharmaceutical development, and vaccine research and development; all of which rely heavily on cytological R&D and transfection. 

Larger market entities are also involved in efforts to expand their market presence in the Asia Pacific region and tap the high potential for growth available. Expected growth of genomic and proteomic research is also a strong factor which will positively impact the growth in demand for transfection. 

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/transfection-
reagents-and-equipment-market

Further key findings from the study suggest:

• Out of both the broad segments of products available, transfection equipment accounted for a larger share of the market in 2014 and owing to their inherently more expensive nature than reagents are expected to maintain this dominant position over the forecast period.
• The market space for transfection has an abundant number of methods to achieve the aforementioned. However, these vary significantly in usage rates and implementation complexities. Electroporation and liposomal transfection combine to account for over 30% of the market owing to high associated advantages.
• Growing applications of transfection techniques poise the segments in a strong position and estimated valuation clocks usage of transfection in gene expression at over USD 130 million and for protein production at over USD 110 million for the year 2014.
• North America was observed to be responsible for the largest share of revenue in 2014 which amounted to a little over USD 240 million. The United States houses the headquarters of operations for a number of market leaders and a number of established research and development. This provides a strong platform for development, manufacture & distribution various vaccines, and biopharmaceuticals which fuels market growth.
• However, it is Asia Pacific region which is anticipated to witness significant growth over the forecast period in various segments owing to considerable growth of cytological research, development of biosimilar drugs and high potential of growth in these relatively untapped regional segments.
• Asia Pacific is expected to grow at a significant rate over the forecast period in terms of increasing production and development of vaccines, drugs, and new biologics. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in biopharmaceutical manufacturing and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.
• Promega, Roche and Thermo Fisher owned Life Technologies accounted for the largest of revenue in 2014 and are involved in new product development for expansion of their portfolios over the forecast period. Acquisition of smaller players is also expected over the forecast period by larger companies
• Key market players in the Transfection Reagent & Equipment Market include BTX (Harvards Apparatus Inc.), SignaGen Laboratories, OriGene Technologies, EMD Millipore, VWR International LLC, Bio-Rad Laboratories Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza AG, Life Technologies (Thermo Fisher), and Promega Corporation. 

View all Related Reports from same Category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented Transfection Reagent & Equipment Market on the basis of product, method, application, and region:

Global Transfection reagents & equipment Product Outlook (Revenue, USD Million, 2012 - 2022)

• Reagents
• Equipment

Global Transfection reagents & equipment Method Outlook (Revenue, USD Million, 2012 - 2022)

• Electroporation
• Liposomes
• Particle Bombardment
• Microinjection
• Adenoviral vectors
• Direct microinjection
• Calcium phosphate
• DEAE-dextran
• Magnetic beads
• Activated Dendrimers
• Laser fection

Global Transfection reagents & equipment Application Outlook (Revenue, USD Million, 2012 - 2022)

• Gene expression studies
• Protein production
• Transgenic delivery
• Cancer research
• Biomedical research

Transfection reagents & equipment Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • U.S.
  • Canada
• Europe
• Germany
• UK
• Japan
• China
• Brazil
• South Africa
• Asia Pacific
• Latin America
• MEA

 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com

Tuberculosis Diagnostics Market SWOT Analysis, By Factor Political, Economic and Technological

Global Tuberculosis Diagnostics Market is expected to reach USD 3.1 billion by 2024, according to a new report by Grand View Research, Inc. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.

These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavours directed toward containing the incidence of this infectious disease.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the end results of these initiatives. This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.

Access for full Detail of Report and Complete TOC: http://www.grandviewresearch.com/industry-analysis/tuberculosis-diagnostics-market

Further key findings from the study suggest:

• Based on tests type, the tuberculosis diagnostics market is segmented into radiographic methods, diagnostic laboratory methods, nucleic acid testing, phage assay, detection of latent infection, cytokine detection assay, and detection of drug resistance.
• Diagnostic laboratory tests dominated the test type segment with 38.0% market share in 2015 as they are cost efficient and easy-to-perform. Diagnostic laboratory tests include smear microscopy and culture-based tests. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies thus contributing to the growth of the diagnostic laboratory tests segment.
• However, compromised accuracy and the longer processing time are the limiting factor for the diagnostics. Hence, healthcare agencies are striving to implement advanced techniques in the developing regions.
• As a result, nucleic acid tests segment and the latent infection detection segment, which includes skin tests and IGRA, are likely to exhibit a profitable growth rate. These methods overcome the aforementioned limitations thus improving affordability, processing time and accuracy of the diagnostic method.
• Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug resistance in TB patients undergoing treatment. Hence, the drug resistance detection segment is also anticipated to witness lucrative growth.
• Asia Pacific owing to its huge population base and high burden of TB dominated the global TB diagnostics market in 2015. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for control of this communicable disease.
• The players in the TB testing market include Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, and QIAGEN.
• New product launches, collaboration, mergers & acquisitions, and regional expansion are the key strategic initiatives undertaken by these industry players
• For instance, in July 2016, bioMérieux launched a novel CE marked database and reagents kit VITEK MS for the identification of TB. This new product launch is anticipated to help the company increase its market share.

View Research Insight on Tuberculosis Diagnostics Market by Grand View Research Report: http://www.grandviewresearch.com/research-insights/tuberculosis-diagnostics-market-tapping-potential-high-burden-geographies-2024 

Grand View Research has segmented the global tuberculosis diagnostics market on the basis of test type, and region.

Global Tuberculosis Diagnostics Test Type Outlook (Revenue, USD Million, 2013 - 2024)

• Radiographic Method
• Diagnostic Laboratory Methods
  • Smear Microscopy
  • Culture-based Test
• Nucleic Acid Testing
• Phage Assay
• Detection of Latent Infection
• Cytokine Detection Assay
• Detection of Drug Resistance
• Other Methods

Tuberculosis Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • U.S.
  • Canada
• Europe
• UK
• Russian Federation
• China
• India
• Brazil
• Mexico
• South Africa
• Asia Pacific
• Latin America
• MEA

 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us@ www.grandviewresearch.com